文献速递肿瘤 PET/CT放射性药物与辐射防护

腺病毒载体新冠疫苗接种相关淋巴结病的FDG PET/CT特征

COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
PubMed 文献 · Clin Nucl Med · 2021-01-01

接种后14天内检查者均出现注射同侧高代谢淋巴结病,且直至23天均伴肌肉摄取;15天后检查的12人中仅3名男性腋窝淋巴结无高代谢,而29天内女性均无阴性表现。

要点

  • 接种腺病毒载体新冠疫苗后14天内FDG PET/CT常见注射同侧腋窝高代谢淋巴结。
  • 高代谢淋巴结病可伴同侧肌肉摄取,持续至接种后23天。
  • 接种后29天内女性腋窝淋巴结高代谢未见转阴,判读时需结合接种史。

核心结论

  • 近期接种腺病毒载体新冠疫苗的健康人FDG PET/CT易出现注射同侧腋窝伴或不伴锁骨上区的高代谢反应性淋巴结病。

研究设计与样本

  • 测量高代谢淋巴结的大小与FDG摄取,并测量脾脏摄取与肝脏比较。

主要发现

  • 所有在接种后14天内接受FDG PET/CT的受检者均显示注射同侧高代谢淋巴结病。
  • 所有伴高代谢淋巴结病的受检者在接种后直至23天内均同时出现肌肉摄取。
  • 接种15天后接受检查的12名受检者中,仅3名男性腋窝淋巴结无高代谢。
  • 接种后直至29天,无女性受检者表现为高代谢淋巴结病阴性。

临床怎么用

  • 判读FDG PET/CT时需询问新冠疫苗接种史,注射同侧腋窝高代谢淋巴结可能为疫苗相关反应性改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study investigated 18F-FDG PET/CT features of adenovirus-vectored vaccination against COVID-19 in healthy subjects. PATIENTS AND METHODS: Thirty-one health care workers had been vaccinated Vaxzevria and underwent FDG PET/CT as an optional test for a cancer screening program. Size and FDG uptake of the hypermetabolic lymph nodes were measured. Uptake value of spleen was also measured with liver for comparison. RESULTS: All examinees who underwent FDG PET/CT within 14 days' interval showed hypermetabolic lymphadenopathies ipsilateral to vaccine injection. All examinees with hypermetabolic lymphadenopathy had simultaneous muscular uptakes until 23 days' interval. Among 12 examinees who underwent FDG PET/CT more than 15 days after vaccination, only 3 male examinees did not show hypermetabolism in the axillary lymph nodes. There was no female examinee with negative hypermetabolic lymphadenopathy until 29 days after vaccination. CONCLUSIONS: Hypermetabolic reactive lymphadenopathy in the ipsilateral axillary area with or without supraclavicular area is most likely to occur in a healthy person with recent adenovirus-vectored COVID-19 vaccination on FDG PET/CT.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Shin M, Hyun CY, Choi YH, et al. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine. Clin Nucl Med. 2021. PMID: 34115709. doi:10.1097/RLU.0000000000003800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。